Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Operating Income: 2020-2024

Historic Operating Income for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to -$202.5 million.

  • Prime Medicine's Operating Income rose 0.48% to -$54.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$204.0 million, marking a year-over-year increase of 9.87%. This contributed to the annual value of -$202.5 million for FY2024, which is 1.14% up from last year.
  • According to the latest figures from FY2024, Prime Medicine's Operating Income is -$202.5 million, which was up 1.14% from -$204.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Operating Income registered a high of -$932,000 during FY2020, and its lowest value of -$204.8 million during FY2023.
  • For the 3-year period, Prime Medicine's Operating Income averaged around -$174.6 million, with its median value being -$202.5 million (2024).
  • Per our database at Business Quant, Prime Medicine's Operating Income slumped by 8,963.73% in 2021 and then rose by 1.14% in 2024.
  • Prime Medicine's Operating Income (Yearly) stood at -$932,000 in 2020, then crashed by 8,963.73% to -$84.5 million in 2021, then plummeted by 37.96% to -$116.5 million in 2022, then crashed by 75.72% to -$204.8 million in 2023, then grew by 1.14% to -$202.5 million in 2024.